WO2019113462 N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2019113462&tab=PCTDESCRIPTION

This is the Patent for the new Merck Pill (molnupiravirfor) for C-19 cure..

Search in page for “Luciferase” and sure enough, yes indeed.. Another deceptive plot from satan.

In April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic properties (producing birth defects).

A previous company, Pharmasset, that had investigated the drug’s active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in animals.

Molnupiravir, EIDD 2801

The Mark of the Beast System is real and here!

Please repent, carry your cross daily and accept the free gift of Jesus Christ’s death on the cross for payment for your sins.

#Yahweh #Yeshua #HolySpirit #LordAlmighty #SovereignLord #Nameaboveallnames #TheWay #TheTruth #TheLife #TheGate #Heaven #KingdomofHeaven  #Saved #Glorified #Endtimes #LastDays #FeastofTrumpets #markofthebeast #verseoftheday #birthpains #Judgement #Christian #Christianity #hope #love #Jesus  #Christ

Leave a Reply Cancel reply

Powered by WordPress.com.

Up ↑

Exit mobile version
%%footer%%